• Skip to primary navigation
  • Skip to main content

New York Society of Addiction MedicineNew York Society of Addiction Medicine Logo

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn
  • Join Mailing List
  • Past Conferences
  • NYSAM News
  • About
    • About NYSAM
    • Leadership
    • About Addiction Medicine
    • Contact NYSAM
    • News
  • Events
    • 2025 Annual Conference Exhibitors and Sponsors
  • Key Issues
    • Advocacy
    • Opioids
    • Marijuana
    • Access to Care
    • More Issues
  • Resources
    • For Patients
    • For Physicians
    • Webinars
    • Articles
    • Employment
  • Membership
    • NYSAM Committees
    • Become a NYSAM Member
    • Renew Membership
    • Our Members
  • Conferences
  • Latest News
  • Donate
  • Sign Up for Our Newsletter

Opioids

Opioids are a class of medications and substances that primarily affect the mu opioid receptor, in the central nervous system. Opioids comprise natural opiates and synthetic and semi-synthetic opioids. Opioids can have a medical purpose for the treatment of pain, like prescribed opioid medications. Opioids can also have a non-medical purpose such as heroin, a substance that can be ingested, inhaled, or injected.

March 30, 2023 by NYSAM

FDA Approves Over-the-Counter Naloxone

On March 29th, the the U.S. Food and Drug Administration (FDA) approved the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. This…

November 9, 2022 by NYSAM

Caring for Patients in Today’s Opioid Landscape

In 2021, overdose deaths in the United States reached a record high. At the same time, restrictions on prescription opioids…

June 16, 2021 by NYSAM

Expanding Access to Medications for Opioid Use Disorder in New York’s Jails and Prisons

Our NYSAM chapter has been working diligently to educate our members on incarceration and opioid use disorder. Strong evidence supports…

September 25, 2019 by NYSAM

The NY Department of Health AIDS Institute Substance Use Guideline Committee Publishes New Guideline: Treatment of Opioid Use Disorder

Two new Substance Use Disorder Treatment Guidelines have just been released and posted on by the AIDS Institute Clinical Guidelines…

August 12, 2019 by Jasmine Landry

JAMA Article Response: Healthcare Providers Should Not Perpetuate Stigmatization

In a piece published in JAMA that discussed last year’s film Beautiful Boy, Dr. Abigail Zuger endorsed the sentiment of…

July 30, 2019 by NYSAM

ASAM Supports Expansion of Access to Buprenorphine Through The Mainstreaming Addiction Treatment Act

ASAM Board Member, Dr. Margaret Jarvis, testified in front of a Congressional Roundtable on the nation’s response to the “third…

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

View by Topic

  • All Topics
  • Access to Care
  • Advocacy
  • Alcohol
  • Benzodiazepines
  • Evidence-based Research
  • Harm reduction
  • Marijuana
  • Opioids
  • Stimulants

Connect with Us

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn

Join our mailing list to stay updated on upcoming events and chapter news.

  • This field is for validation purposes and should be left unchanged.

NYSAM is a State Chapter of the American Society of Addiction Medicine (ASAM)

  • Become a Member
  • About Addiction Medicine
  • Addiction Resources
  • Physician Resources
  • Key Issues
NYSAM logo in footer

1 Capitol Mall Ste 800
Sacramento, CA 95814

For inquiries, contact Kim Andosca, Executive Director
209-499-9045
nysam@amgroup.us

© 2025 New York Society of Addiction Medicine. Website by Status Forward.